文献速递关节外科骨质疏松与代谢性骨病

高交联聚乙烯全髋关节置换术治疗股骨头坏死的长期生存率

Long-Term Survivorship of Total Hip Arthroplasty with Highly Cross-Linked Polyethylene for Osteonecrosis.
PubMed 文献 · J Bone Joint Surg Am · 2019-01-01

本研究比较了股骨头坏死与骨关节炎患者使用高交联聚乙烯内衬行初次全髋关节置换术的长期假体生存率、功能结局和影像学结果。中位随访10年,坏死组15年翻修累积率为6.6%,骨关节炎组为4.5%(HR=1.8,p=0.09);任何再手术累积率分别为10.5%和6.4%(HR=2.2,p=0.008)。两组功能评分术后均显著改善且相似,无影像学松动或骨溶解征象。

要点

  • 股骨头坏死组15年再手术累积率高于骨关节炎组(10.5% vs 6.4%,HR=2.2,p=0.008)。
  • 两组15年翻修累积率无显著差异(6.6% vs 4.5%,HR=1.8,p=0.09)。
  • 特发性股骨头坏死亚组15年再手术累积率最高(25%),放疗后坏死组为0%。

核心结论

  • 现代高交联聚乙烯内衬全髋关节置换术为股骨头坏死患者提供优异的长期假体生存率和功能结局,但与骨关节炎患者相比再手术风险更高。

研究设计与样本

  • 回顾性匹配队列研究,从机构全关节登记系统识别1999年至2007年行初次全髋关节置换术并使用高交联聚乙烯内衬的患者。
  • 股骨头坏死组461髋(413例)按年龄、性别和体重指数1:1匹配骨关节炎组461髋(427例),平均年龄59岁,47%女性,平均体重指数29 kg/m²,中位随访10年。

主要发现

  • 15年翻修累积率股骨头坏死组为6.6%,骨关节炎组为4.5%(HR=1.8,p=0.09)。
  • 15年任何再手术累积率股骨头坏死组为10.5%,骨关节炎组为6.4%(HR=2.2,p=0.008)。
  • 全队列无影像学假体松动或骨溶解征象;尽管股骨头坏死组术前Harris髋关节评分中位数较低,两组术后各时间点评分均显著改善且相似。
  • 股骨头坏死亚组15年再手术累积率:放疗后坏死0%,酒精性坏死6.3%,创伤后坏死9.0%,激素性坏死12.1%,特发性坏死25%。

局限性

  • 证据等级为预后Level III。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Osteonecrosis of the hip is the underlying etiology for 3% to 12% of total hip arthroplasties (THAs). Compared with patients who undergo THA because of osteoarthritis, those who do so because of osteonecrosis typically are younger, have a greater number of underlying diagnoses, and have inferior clinical outcomes and implant survivorship. The purpose of this study was to compare the long-term implant survivorship (median follow-up, 10 years), functional outcomes, and radiographic results of contemporary THAs with a highly cross-linked polyethylene (HXLPE) liner between patients with osteonecrosis and those with osteoarthritis. METHODS: All patients who underwent primary THA with an HXLPE liner from 1999 to 2007 were identified from our institutional total joint registry. Patients with a primary diagnosis of osteonecrosis were matched 1:1, on the basis of age, sex, and body mass index (BMI), to patients with a diagnosis of osteoarthritis. This resulted in 461 hips in 413 patients with osteonecrosis matched to 461 hips in 427 patients with osteoarthritis (mean age, 59 years; 47% female; and mean BMI, 29 kg/m). Long-term implant survivorship, patient-reported outcomes, and radiographic findings were compared. In addition, a subgroup analysis of the osteonecrosis group was performed to see whether certain underlying etiologies portended poor outcomes. The median follow-up was 10 years. RESULTS: The 15-year cumulative rates of revision were 6.6% and 4.5% in the osteonecrosis and osteoarthritis groups, respectively (hazard ratio [HR] = 1.8, p = 0.09). The 15-year cumulative rates of any reoperation were 10.5% and 6.4% in the osteonecrosis and osteoarthritis groups, respectively (HR = 2.2, p = 0.008). There were no radiographic signs of component loosening or osteolysis in the entire cohort. Despite a lower median preoperative Harris hip score (HHS) for patients with osteonecrosis, both groups had marked improvements in their scores, which were similar at all time points after surgery. The cumulative rate of reoperations at 15 years was 0% for hips with radiation-induced osteonecrosis, 6.3% for those with alcohol-induced osteonecrosis, 9.0% for those with posttraumatic osteonecrosis, 12.1% for those with steroid-induced osteonecrosis, and 25% for those with idiopathic osteonecrosis. CONCLUSIONS: Contemporary THA with an HXLPE liner offers excellent long-term implant survivorship and functional outcomes for patients with osteonecrosis; however, the risk of a reoperation is higher when compared with patients with osteoarthritis. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Hart A, Janz V, Trousdale RT, et al. Long-Term Survivorship of Total Hip Arthroplasty with Highly Cross-Linked Polyethylene for Osteonecrosis. J Bone Joint Surg Am. 2019. PMID: 31483399. doi:10.2106/JBJS.18.01218

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。